Pharmaceutical Business review

Marshall Edwards announces resignation of board member

Mr Breckenridge was the chairman of the audit committee and served as the audit committee financial expert. He also served as a member of the compensation committee.

The board has appointed William Rueckert, an existing member of the board, as chairman of the audit committee.

As a result of Mr Breckenridge’s resignation, the size of the board of directors has decreased from six to five members.